The U.S. Food & Drug Administration will host a public meeting this Thursday, Nov. 19 to discuss whether CBD and other cannabinoids have different effects on men and women. FDA said the meeting should interest researchers, educators, clinicians and patients. Other presentations will address patient and healthcare provider perspectives on CBD and other cannabinoids, use of CBD and other cannabinoids in pregnancy, and government agency perspectives on CBD research.
FDA meeting will explore gender, CBD
Like HempToday? How you can support us
Your donations help us to keep HempToday open for all readers, regardless of what they can afford to pay. Through this “information equality” we're able to support hemp entrepreneurs and stakeholders all over the world by keeping a spotlight on hemp and all the promise it offers for economic development and healing our planet.
